UCLA RAD ONC AT ASTRO 2024 - Flipbook - Page 8
TUESDAY, OCTOBER 1, 2024
Tuesday, October 1 at 2:30PM
SESSION: PQA 08 - PQA 08 Genitourinary Cancer, Patient Safety, and
Nursing/Supportive Care Poster Q&A / 3199 - Convolutional Neural
Network Model Processing of Intraprostatic Piflufolastat F-18 [18FDCFPyL] PSMA PET/CT Imaging Data can Predict the Presence of
Synchronous Metastases in Patients with Newly Diagn
PRESENTER: JESUS JUAREZ CASILLAS, MD, MS
LOCATION: Hall C
Tuesday, October 1 at 2:30PM
SESSION: PQA 08 - PQA 08 Genitourinary Cancer, Patient Safety, and
Nursing/Supportive Care Poster Q&A / 3250 - Phase 2 Prospective Trial
of Re-Treatment with 177lu-PSMA-617 Molecular Radiotherapy for
Metastatic Castration Resistant Prostate Cancer (RE-LuPSMA): Study
Protocol
PRESENTER: JOHN NIKITAS, MD
LOCATION: Hall C
Tuesday, October 1 at 2:30PM
SESSION: PQA 08 - PQA 08 Genitourinary Cancer, Patient Safety, and
Nursing/Supportive Care Poster Q&A / 3304 - A Pilot Study of
Immunological Response to PSMA-Directed Radioligand Therapy for the
Treatment of Oligometastatic Prostate Cancer
PRESENTER: LUCA VALLE, MD
LOCATION: Hall C
Tuesday, October 1 at 4:00PM
SESSION: SS 38 - GU 2: Optimizing the Therapeutic Ratio in Prostate
Cancer / 317 - Magnetic Resonance Imaging-Guided vs .Computed
Tomography-Guided Stereotactic Body Radiotherapy for Prostate
Cancer: 2-Year Outcomes from the MIRAGE Randomized Clinical Trial
PRESENTER: AMAR KISHAN, MD
LOCATION: Room 202